bioRxivCell Biology
ER-lysosome lipid transfer protein VPS13C/PARK23 prevents aberrant mtDNA-dependent STING signaling
W. F. Hancock-Cerutti, Z. Wu, A. K. Tharkeshwar, S. M. Ferguson, G. S. Shadel, P. De Camilli
Abstract
Mutations in VPS13C cause early onset, autosomal recessive Parkinsons Disease (PD). We have established that VPS13C encodes a lipid transfer protein localized to contact sites between the endoplasmic reticulum (ER) and late endosomes/lysosomes. In the current study, we demonstrate that depleting VPS13C in HeLa cells causes an accumulation of lysosomes with an altered lipid profile, including an accumulation of di-22:6-BMP, a biomarker of the PD-associated leucine-rich repeat kinase 2 (LRRK2) G2019S mutation. In addition, the DNA-sensing cGAS/STING pathway, which was recently implicated in PD pathogenesis, is activated in these cells. This activation results from a combination of elevated mitochondrial DNA in the cytosol and a defect in the degradation of activated STING, a lysosome-dependent process. These results suggest a link between ER-lysosome lipid transfer and innate immune activation and place VPS13C in pathways relevant to PD pathogenesis.
- organism: human
- assay: proteomics
- assay: metabolomics
- research focus: cell type annotation
- research focus: differential expression
- research focus: cell signaling & trafficking
- research focus: cancer & tumor microenvironment
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Lysosome damage triggers acute formation of ER to lysosomes membrane tethers mediated by the bridge-like lipid transport protein VPS13C
Xinbo Wang, Peng Xu, … Pietro V. De Camilli·Nature Cell BiologyPeer-reviewed·Apr 10, 2025
- VPS13C/PARK23 initiates lipid transfer and membrane remodeling for efficient lysosomal repair
Oluwatobi Andrew Adeosun, Christian Schröer, … Joost C. M. Holthuis·Nature CommunicationsPeer-reviewed·Jul 2, 2026
- The Parkinson's Disease related mutant VPS35 (D620N) amplifies the LRRK2 response to endolysosomal stress
K. R. McCarron, H. Elcocks, … M. J. Clague·bioRxiv·Dec 2, 2023
- Lysosomal perturbations in dopaminergic neurons derived from induced pluripotent stem cells with PARK2 mutation
Justyna Okarmus, Helle Bogetofte, … Morten Meyer·Scientific ReportsPeer-reviewed·Jun 24, 2020
- VPS13A and VPS13C influence lipid droplet abundance
S. Chen, M. A. Roberts, … S. Ferro-Novick·bioRxiv·Jun 21, 2022
- The LRRK2 G2019S mutation alters astrocyte-to-neuron communication via extracellular vesicles and induces neuron atrophy in a human iPSC-derived model of Parkinson's disease
Aurélie de Rus Jacquet, Jenna L Tancredi, … Erin K. O’Shea·eLifePeer-reviewed·Sep 30, 2021